Paris - Delayed Quote EUR
Pharnext S.C.A. (ALPHA.PA)
At close: August 26 at 5:10 PM GMT+2
Key Executives
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Daniel E. Cohen M.D., Ph.D. | Director | 319.3k | -- | 1953 |
| Mr. Hugo Brugiere M.Sc. | CEO & Chairman | -- | -- | -- |
| Mr. Ilya Chumakov D-Sc, Ph.D. | Co-Founder, Chairman of Scientific Advisory Board and Director | -- | -- | -- |
| Mr. Vincent Serra Ph.D. | COO & Chief Scientific Officer | -- | -- | 1970 |
| Mr. Raj Thota M.Sc. | Chief Manufacturing Officer & Head of CMC | -- | -- | -- |
| Mr. Gilbert Wagener M.D., Ph.D. | Chief Medical Officer | -- | -- | -- |
Pharnext S.C.A.
14 rue de la REpublique
Suresnes, 92150
France
- Sector:?
- Healthcare
- Industry:? Biotechnology
Description
Pharnext S.C.A., a clinical-stage biopharmaceutical company, engages in developing novel therapies for neurodegenerative diseases. Its products in clinical development include PXT3003, a synergistic combination of baclofen, naltrexone, and sorbitol formulated as an oral solution for the treatment of charcot-marie-tooth disease type 1A; and PXT864, a novel fixed-dose synergistic combination of baclofen and acamprosate formulated as a pill for neurodegenerative diseases. The company was incorporated in 2007 and is headquartered in Suresnes, France.
Corporate Governance
Pharnext S.C.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 30, 2024 at 10:59 AM UTC
Pharnext S.C.A. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
MEDCL.PA MedinCell S.A.
17.94
+1.93%
CRGX CARGO Therapeutics, Inc.
22.50
+4.70%
JSPR Jasper Therapeutics, Inc.
22.91
+0.97%
CAMP CAMP4 THERAPEUTICS CORPORATION
10.15
-3.33%
PTCT PTC Therapeutics, Inc.
44.38
+3.31%
AGIO Agios Pharmaceuticals, Inc.
58.90
+6.93%
ASND Ascendis Pharma A/S
124.73
-1.44%
ZVRA Zevra Therapeutics, Inc.
8.85
+0.45%
SRRK Scholar Rock Holding Corporation
28.89
-0.22%
CORT Corcept Therapeutics Incorporated
59.87
+10.26%